ONCOSEC MED INC - COM NEW (ONCS)

CUSIP: 68234L207

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
4,132,452
Share change
-3,280,047
Total reported value
$2,643,000
Price per share
$0.64
Number of holders
31
Value change
-$3,736,440
Number of buys
18
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q4 2018

As of 31 Dec 2018, ONCOSEC MED INC - COM NEW (ONCS) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,132,452 shares. The largest 10 holders included Vanguard Group Inc, Anson Funds Management LP, BlackRock Inc., Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, A.R.T. Advisors, LLC, and D.A. DAVIDSON & CO.. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.